Micreos
| Industry | Biotechnology |
|---|---|
| Founded | 2005 |
| Founder | Mark Offerhaus |
| Headquarters | Netherlands |
| Products |
|
Number of employees | 50-200 |
| Website |
www |
Micreos is a Netherlands-based phage- and endolysin technology development company.[1] The company is the developer of Staphefekt, an endolysin that selectively kills Staphylococcus aureus bacteria.[2] The substance is an ingredient in the firm's skincare brand Gladskin[3] which targets inflammatory skin conditions.
Micreos has developed phage- and endolysin-based products against specific bacteria such as Listeria, Salmonella and MRSA. Listex is their antimicrobial processing aid used to prevent Listeria in food products including meat, fish and cheese. The USDA, Health Canada, and FSANZ have approved these uses.[4][5] Salmonelex, aimed at prevention of cross contamination and the killing of undesirable Salmonella bacteria on food during processing - has been approved as a GRAS processing aid by the FDA. Mark Offerhaus serves as the company’s CEO.[6]
External links
References
- ↑ "Scientific Opinion on the evaluation of the safety and efficacy of ListexTM P100 for the removal of Listeria monocytogenes surface contamination of raw fish". EFSA Journal. Retrieved Sep 27, 2013.
- ↑ Herpers, B.L. (May 10, 2014). "Specific lysis of methicillin susceptible and resistant Staphylococcus aureus by the endolysin Staphefekt SA.100™" (PDF). European Congress of Clinical Microbiology and Infectious Diseases.
- ↑ "How Gladskin works". www.gladskin.com. Retrieved 2016-11-24.
- ↑ "Listeria-killing phage product gets FSANZ approval". Food Production Daily. Retrieved Sep 27, 2013.
- ↑ "Antimicrobial Umbrella Helps Deli Supplier Walk Food Safety Tightrope". The Global Fruit. Retrieved Sep 27, 2013.
- ↑ "Team - Micreos.com". www.micreos.com. Retrieved 2016-09-15.